Literature DB >> 9311888

Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8.

C Blasig1, C Zietz, B Haar, F Neipel, S Esser, N H Brockmeyer, E Tschachler, S Colombini, B Ensoli, M Stürzl.   

Abstract

PCR analysis and serological studies demonstrated a close association between Kaposi's sarcoma (KS)-associated herpesvirus, or human herpesvirus 8 (HHV-8), and the development of Kaposi's sarcoma (KS). The majority of the KS cells were shown to be latently infected by the virus. In this study we investigated which type of cell is productively infected in KS lesions. In situ hybridization was performed with strand-specific RNA probes complementary to the sequences coding for the minor capsid protein (VP23) of HHV-8. The VP23 gene is specifically expressed during the lytic or replicative period of the virus life cycle, and therefore it is a useful marker to detect productively infected cells. By in situ hybridization of KS lesions, a strong hybridization signal was detected only in a small subset of the KS cells of the lesions. Simultaneous application of immunohistochemical staining and in situ hybridization identified the virus-replicating cells to be of monocytic origin. Productively infected monocytes may be an important reservoir for transmission of the virus and for the increase and maintenance of the high load of HHV-8 generally observed in nodular KS lesions during late stages of infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311888      PMCID: PMC192155          DOI: 10.1128/JVI.71.10.7963-7968.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

Review 1.  Cellular and molecular features of HIV-associated Kaposi's sarcoma.

Authors:  W K Roth; H Brandstetter; M Stürzl
Journal:  AIDS       Date:  1992-09       Impact factor: 4.177

Review 2.  Kaposi's sarcoma: a review of gene expression and ultrastructure of KS spindle cells in vivo.

Authors:  M Stürzl; H Brandstetter; W K Roth
Journal:  AIDS Res Hum Retroviruses       Date:  1992-10       Impact factor: 2.205

3.  Kaposi's sarcoma in Uganda: a clinico-pathological study.

Authors:  J F Taylor; A C Templeton; C L Vogel; J L Ziegler; S K Kyalwazi
Journal:  Int J Cancer       Date:  1971-07-15       Impact factor: 7.396

4.  Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma.

Authors:  M Stürzl; C Blasig; A Schreier; F Neipel; C Hohenadl; E Cornali; G Ascherl; S Esser; N H Brockmeyer; M Ekman; E E Kaaya; E Tschachler; P Biberfeld
Journal:  Int J Cancer       Date:  1997-07-03       Impact factor: 7.396

Review 5.  Secondary neoplasms as a consequence of transplantation and cancer therapy.

Authors:  I Penn
Journal:  Cancer Detect Prev       Date:  1988

6.  Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells.

Authors:  F L Sciacca; M Stürzl; F Bussolino; M Sironi; H Brandstetter; C Zietz; D Zhou; C Matteucci; G Peri; S Sozzani
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

7.  Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells.

Authors:  J A Regezi; L A MacPhail; T E Daniels; Y G DeSouza; J S Greenspan; D Greenspan
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

8.  Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance.

Authors:  M Stürzl; W K Roth; N H Brockmeyer; C Zietz; B Speiser; P H Hofschneider
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

9.  Occurrence, clinical behaviour and management of Kaposi's sarcoma in Zambia.

Authors:  A C Bayley
Journal:  Cancer Surv       Date:  1991

10.  Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

Authors:  V Beral; T A Peterman; R L Berkelman; H W Jaffe
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

View more
  102 in total

1.  Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents.

Authors:  J P Zoeteweij; S T Eyes; J M Orenstein; T Kawamura; L Wu; B Chandran; B Forghani; A Blauvelt
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Infection of primary human monocytes by Epstein-Barr virus.

Authors:  M Savard; C Bélanger; M Tardif; P Gourde; L Flamand; J Gosselin
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus.

Authors:  K Nealon; W W Newcomb; T R Pray; C S Craik; J C Brown; D H Kedes
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells.

Authors:  P Monini; F Carlini; M Stürzl; P Rimessi; F Superti; M Franco; G Melucci-Vigo; A Cafaro; D Goletti; C Sgadari; S Butto'; P Leone; C Chiozzini; C Barresi; A Tinari; A Bonaccorsi; M R Capobianchi; M Giuliani; A di Carlo; M Andreoni; G Rezza; B Ensoli
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

5.  Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  V Varthakavi; P J Browning; P Spearman
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse.

Authors:  Hong-Guang Guo; Mariola Sadowska; William Reid; Erwin Tschachler; Gary Hayward; Marvin Reitz
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

7.  Activation of plasmacytoid dendritic cells by Kaposi's sarcoma-associated herpesvirus.

Authors:  John A West; Sean M Gregory; Vijay Sivaraman; Lishan Su; Blossom Damania
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

8.  Latent Kaposi's sarcoma-associated herpesvirus infection of monocytes downregulates expression of adaptive immune response costimulatory receptors and proinflammatory cytokines.

Authors:  Sean M Gregory; Ling Wang; John A West; Dirk P Dittmer; Blossom Damania
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

9.  Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

Authors:  C Parravicini; B Chandran; M Corbellino; E Berti; M Paulli; P S Moore; Y Chang
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

10.  Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acid.

Authors:  Laurie T Krug; Veronika P Pozharskaya; Yimin Yu; Naoki Inoue; Margaret K Offermann
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.